Eli Lilly said on Thursday it will start late-stage trials of its experimental obesity drug next month after it helped patients lose as much as 20.1% of their weight in a mid-stage trial. The ...

Lilly Pulitzer Spring/Summer 2026 collection converts joy into a sustained market power.

Eli Lilly on Monday, Dec. 1 slashed prices of its blockbuster weight loss drug Zepbound for consumers who buy the prescription medication directly from the drugmaker. Lilly's price cuts ranged from ...

For more than six decades, Lilly Pulitzer has been synonymous with colorful, eye-catching resortwear, often featuring playful motifs. Several prints have been released over the years, but ahead of ...

Eli Lilly & Co.’s obesity pill prompted enough weight loss in a large clinical trial to be meaningful for patients and have far-reaching implications for the field, doctors said. The US drugmaker’s ...

On Thursday, August 7, Eli Lilly's stock (NYSE:LLY) dropped by 14%, even though the company announced a strong quarter with earnings, revenues, and guidance that exceeded market expectations. This ...

Lilly’s return to the JP Morgan Healthcare Conference comes as the company seeks to shift the narrative from last year’s ...

Eli Lilly's obesity drugs delivered 38% revenue growth in the second quarter; but its oral GLP-1 candidate fell short, achieving only 12.4% weight loss. Viking Therapeutics' dual-formulation obesity ...

The heritage American brand recently regained the copyrights for vintage patterns from the ‘60s, ‘70s, and ‘80s, and showed them off in modern fashion in Key West.

A next-generation obesity shot from Eli Lilly and Co. helped patients lose almost a quarter of their body weight, potentially ...